New initiative to INDICATE cancer risk

Published on
I am proud to be part of a new international collaborative initiative, called INDICATE, to unravel the role of the Human Leukocyte Antigen type as a cancer risk modifier in individuals with Lynch syndrome.

Further developments within the project will be regularly posted on the INDICATE website.